Train Blast in Pakistan Kills at Least 20 Heightening Geopolitical Risk for Investors Security Incident Near White House Raises Concerns Over Government Stability Prediction Market Investments Surge Despite Regulatory Uncertainty June Quarter Earnings Seen as Key Market Catalyst Amid Geopolitical Risks Says Expert Zydus Lifesciences Revises Buyback Terms Price Hiked to Rs 1260 Share Count Reduced Global Oil Supply Disruptions Reshape Energy Demand Patterns FAF Q1 2026 Earnings EPS Beat by 256 Despite Mixed Market Reaction Soligenix SNGX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Slips CNSP Q1 2026 Earnings WiderThanExpected Loss but Stock Gains 7 on Strategic Updates SPRB Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Sentiment WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results Upbound Group Inc UPBD Rises 151 Testing Resistance Near 19 Amid Volume Patterns Miluna Acquisition Corp MMTX Holds Steady at 1007 as SPAC Trading Remains Directionless Forafric Global Warrants AFRIW Consolidate Near Resistance at 080 Sanofi ADS SNY Tests Support Levels After Modest Decline Nasus Pharma NSRX Edges Higher Approaches Key Resistance Level Universe Pharmaceuticals Inc UPC Surges 9 as Momentum Builds Near Key Resistance Texas Ventures Acquisition III Warrants TVACW Climb 392 Approaching Key Resistance OS Therapies OSTX Edges Higher Testing Key Levels After Modest Gain Hercules Capital HTGC Rallies 209 as Stock Approaches Key Resistance Level Zenta Group Limited ZGM Holds Steady at 165 as Trading Range Narrows Sonoma Pharmaceuticals SNOA Edges Higher Testing Resistance at 113 Alberta to Hold Referendum on Separation from Canada Separatist Campaign Culminates Allegion ALLE Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges Veeva Systems VEEV Holds Above Support After Modest Gain Cautious Trend Continues Navios Maritime Partners NMM Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures JBLU Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Persist CLS Q1 2026 Earnings EPS Surpasses Estimates Stock Rises AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment SIBONE Inc SIBN Q1 2026 Earnings Narrowerthanexpected Loss Drives 48 EPS Surprise Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates as Clinical Progress Drives Share Gains